查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944483

全球治療性神經毒素市場：產業分析、市場規模、佔有率及2025-2032年預測（按類型、應用、最終用戶、國家和地區分類）

Therapeutic Neurotoxin Market, By Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年治療性神經毒素市場規模價值為62.3465億美元，從2025年到2032年將以8.53%的複合年成長率成長。

治療性神經毒素是生物來源的蛋白質毒素，其中最常見的是純化的肉毒桿菌。它們以受控的醫療劑量用於治療多種神經系統、肌肉系統和腺體系統的疾病。臨床使用的神經毒素透過抑制神經肌肉接頭處乙醯膽鹼的釋放發揮作用，從而降低肌肉活動並導致神經活動異常。治療性神經毒素的作用機制使其可用於治療慢性偏頭痛、痙攣、頸部肌張力不全症、膀胱過動症、多汗症和某些運動障礙，以及用於美容目的。經過適當訓練的醫護人員可以使用治療性神經毒素產生標靶作用，且此作用永續直至逆轉。這使得這些神經毒素成為有效的治療方法，能夠帶來醫療益處並改善生活品質。

治療性神經毒素的市場動態

對微創美容手術的需求日益成長

由於微創美容療程的趨勢日益成長，治療性神經毒素市場正在蓬勃發展。患者越來越傾向於選擇非手術治療，這些治療療程短、無需恢復期、不適感小、健康風險低，卻能帶來顯著的美容效果。治療性神經毒素的組合療法，能夠快速有效地減少臉部皺紋和細紋，使其成為吸引各類客戶的理想選擇。隨著人們對臉部美的關注度不斷提高，社群媒體平台不斷推崇新的美學標準，以及美容療程越來越被老年人所接受，這一趨勢仍在持續。隨著注射技術和產品配方不斷提升安全性和療效標準，診所和醫療美容中心能夠提供重複治療，加速市場成長。安全性和療效的雙重進步，促使更多診所和醫療美容中心採用這些產品，進一步鞏固了市場地位。

治療性神經毒素市場：細分分析

按類型

截至2024年，A型肉毒桿菌毒素佔據市場主導地位。其經臨床驗證的療效和安全性，以及其核准的多種醫療和美容用途，構成了市場的基礎。 A型肉毒桿菌毒素的醫療用途包括治療慢性偏頭痛、痙攣和頸肌肌張力不全症、膀胱過動症和多汗症，同時在非手術美容治療中也廣受歡迎。其廣泛的監管核准歷史，以及完善的臨床資料庫，贏得了醫生的高度信賴和患者的廣泛接受，從而推動了治療的持續進行和穩定的產品需求。

治療性神經毒素市場—區域分析

北美引領著整個產業。這一市場擴張主要受三大區域因素驅動：美國及其周邊市場憑藉先進的醫療設施和高所得水平，持續將神經毒素產品用於治療和美容用途。微創療法在治療慢性偏頭痛、痙攣、膀胱過動症和多汗症方面的日益普及，使得醫療專業人員能夠將這些療法應用於非美容領域，從而拓展收入來源。監管核准與新型配方和適應症的產品開發之間的協同作用，有望在未來創造新的治療選擇，並進一步提高醫療專業人員和患者的接受度。

目錄

第1章 治療性神經毒素市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

3. 治療性神經毒素的關鍵市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

4. 治療性神經毒素市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

5. 治療性神經毒素市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：治療性神經毒素市場概況

  • 治療性神經毒素市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 治療性神經毒素市場（按類型分類）

  • 概述
    • 細分市場佔有率分析：按類型
    • A型肉毒桿菌毒素
    • B型肉毒桿菌

8. 按應用分類的治療性神經毒素市場

  • 概述
    • 細分市場佔有率分析：按應用
    • 慢性偏頭痛
    • 眼瞼痙攣
    • 膀胱過動症
    • 痙攣
    • 頸部肌肌張力不全症
    • 其他

9. 按最終用戶分類的治療性神經毒素市場

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院
    • 專科診所
    • 其他

10. 各地區治療性神經毒素市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析—治療性神經毒素產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • AbbVie Inc.
    • Croma-Pharma GmbH
    • Ipsen SA
    • Daewoong Pharmaceutical Co. Ltd.
    • Supernus Pharmaceuticals
    • Merz Pharma GmbH &Co KGaA
    • Hugel Inc.
    • Galderma Inc.
    • Medytox Inc.
    • Evolus Inc.
    • Revance Therapeutics Inc.

第12章：分析師視角360度分析

簡介目錄
Product Code: ANV6036

The Therapeutic Neurotoxin Market size was valued at US$6,234.65 Million in 2024, expanding at a CAGR of 8.53% from 2025 to 2032.

Therapeutic neurotoxins are biologically derived protein toxins most commonly purified forms of botulinum toxin that are used in controlled, medical doses to treat a wide range of neurological, muscular, and glandular disorders. The neurotoxins used in clinical practice function by stopping acetylcholine release at neuromuscular junctions which leads to decreased muscle activation and abnormal nerve activity. The mechanism of action in therapeutic neurotoxins enables their use for treating chronic migraine spasticity cervical dystonia overactive bladder, hyperhidrosis and specific movement disorders together with their popular cosmetic uses. Healthcare professionals who receive appropriate training can use therapeutic neurotoxins to produce targeted effects that last until the effects need to be reversed making these neurotoxins an efficient treatment method that provides medical advantages and enhances life quality.

Therapeutic Neurotoxin Market- Market Dynamics

Rising demand for minimally invasive aesthetic procedures

The therapeutic neurotoxin market experiences growth because more people want to undergo minimally invasive aesthetic treatments. Patients increasingly prefer non-surgical treatments which provide visible aesthetic improvements through short procedures that require no recovery time, minimal discomfort and low chances of danger to their health. The combination of therapeutic neurotoxins which deliver fast outpatient procedures that reduce facial wrinkles and fine lines has created a treatment option which appeals to diverse customers. The trend continues because people become more aware of facial aesthetics and social media platforms promote aesthetic standards and both younger and older generations show greater acceptance of cosmetic procedures. The market growth accelerates because injection techniques and product formulations have reached new safety and treatment outcome standards which encourage clinics and medical spas to offer repeat treatments. The dual advance of safety and treatment outcomes strengthens the market because more clinics and medical spas adopt these products.

Therapeutic Neurotoxin Market- Segmentation Analysis:

By Type

In 2024, the botulinum toxin type A dominated the market. The market functions mainly because of its proven clinical effectiveness and safety record, as well as its multiple approved medical and cosmetic uses. The medical use of botulinum toxin type A extends to chronic migraine, spasticity and cervical dystonia, overactive bladder, hyperhidrosis, and its high popularity in non-surgical cosmetic treatments. The combination of its extensive regulatory approval history and its comprehensive clinical database has created high trust among doctors and strong acceptance among patients, resulting in ongoing treatment and steady product demand.

Therapeutic Neurotoxin Market- Geographical Insights

North America leads the industry. The expansion of this market relies on three primary regional factors. The United States, together with its nearby markets, uses advanced medical facilities and high-income levels to sustain both therapeutic and cosmetic usage of neurotoxin products. The growing popularity of minimally invasive treatments for chronic migraine and spasticity, overactive bladder, and hyperhidrosis conditions has permitted medical professionals to use these procedures for more than just cosmetic reasons, which has resulted in a larger income stream. The combination of regulatory approvals and product development for new formulations and indications has created additional treatment options, which medical professionals and patients will increasingly adopt.

Therapeutic Neurotoxin Market- Competitive Landscape:

The therapeutic neurotoxin market functions as an oligopoly while it continues to experience market changes because three major established companies control worldwide sales but new competitors, local producers and biosimilar products now enter the market to create price competition and develop new medical applications. The global market leaders AbbVie/Allergan (BOTOX(R)), Ipsen (DYSPORT(R)), and Merz (XEOMIN(R)) together control most branded sales because their products have extensive clinical backgrounds and multiple approved uses and their brand names are well-known to doctors and patients.

Recent Developments:

In September 2025, Allergan Aesthetics, an AbbVie company announced a new chapter for BOTOX(R) Cosmetic with the debut of "The One & Only" campaign, a national, multichannel marketing initiative that champions self-expression and individuality. BOTOX(R) Cosmetic became the first and only brand to achieve this milestone because it now holds the status of the top-selling neurotoxin worldwide, which has received FDA approval for more aesthetic treatment areas than any other product in its category.

In April 2025, AbbVie has filed a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for their product trenibotulinumtoxinE (TrenibotE) which treats moderate to severe glabellar lines.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC NEUROTOXIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc.
  • Croma-Pharma GmbH
  • Ipsen SA
  • Daewoong Pharmaceutical Co. Ltd.
  • Supernus Pharmaceuticals
  • Merz Pharma GmbH & Co KGaA
  • Hugel Inc.
  • Galderma Inc.
  • Medytox Inc.
  • Evolus Inc.
  • Revance Therapeutics Inc.

GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Botulinum Toxin Type A
  • Botulinum Toxin Type B

GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Chronic Migraine
  • Blepharospasm
  • Overactive Bladder
  • Spasticity
  • Cervical Dystonia
  • Others

GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Others

GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Therapeutic Neurotoxin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Therapeutic Neurotoxin Market Snippet by Type
    • 2.1.2. Therapeutic Neurotoxin Market Snippet by Application
    • 2.1.3. Therapeutic Neurotoxin Market Snippet by End-User
    • 2.1.4. Therapeutic Neurotoxin Market Snippet by Country
    • 2.1.5. Therapeutic Neurotoxin Market Snippet by Region
  • 2.2. Competitive Insights

3. Therapeutic Neurotoxin Key Market Trends

  • 3.1. Therapeutic Neurotoxin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Therapeutic Neurotoxin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Therapeutic Neurotoxin Market Opportunities
  • 3.4. Therapeutic Neurotoxin Market Future Trends

4. Therapeutic Neurotoxin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Therapeutic Neurotoxin Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Therapeutic Neurotoxin Market Landscape

  • 6.1. Therapeutic Neurotoxin Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Therapeutic Neurotoxin Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Botulinum Toxin Type A
    • 7.1.3. Botulinum Toxin Type B

8. Therapeutic Neurotoxin Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 8.1.2. Chronic Migraine
    • 8.1.3. Blepharospasm
    • 8.1.4. Overactive Bladder
    • 8.1.5. Spasticity
    • 8.1.6. Cervical Dystonia
    • 8.1.7. Others

9. Therapeutic Neurotoxin Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024&2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty Clinics
    • 9.1.4. Others

10. Therapeutic Neurotoxin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Therapeutic Neurotoxin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Therapeutic Neurotoxin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Therapeutic Neurotoxin Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Therapeutic Neurotoxin Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Therapeutic Neurotoxin Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Therapeutic Neurotoxin Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Croma-Pharma GmbH
    • 11.2.3. Ipsen SA
    • 11.2.4. Daewoong Pharmaceutical Co. Ltd.
    • 11.2.5. Supernus Pharmaceuticals
    • 11.2.6. Merz Pharma GmbH & Co KGaA
    • 11.2.7. Hugel Inc.
    • 11.2.8. Galderma Inc.
    • 11.2.9. Medytox Inc.
    • 11.2.10. Evolus Inc.
    • 11.2.11. Revance Therapeutics Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us